Summary & Overview
CPT 88188: Flow Cytometry Interpretation, 9–15 Markers
CPT code 88188 denotes the clinical interpretation of flow cytometry studies that include nine to 15 markers, typically performed by a pathologist or clinical laboratory physician. This code captures the professional interpretive component of multiparameter flow cytometry used in hematopathology and immunophenotyping, and is nationally relevant given the central role of flow cytometry in diagnosing hematologic malignancies, immune disorders, and monitoring therapy.
Key payers examined include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and coding scope, payer coverage considerations, and benchmarking insights where available. The publication outlines common billing practices for interpretation-only services, the typical clinical settings where 88188 is reported, and how this code fits within laboratory and pathology service lines.
The analysis provides national-level context rather than state-specific guidance. Where input data was not provided, the report notes the absence of payer-specific policy details, associated taxonomies, diagnoses, and related codes. The content is designed to inform coding professionals, laboratory administrators, and policy analysts about the clinical purpose, typical use cases, and payer landscape relevant to CPT code 88188.
Billing Code Overview
CPT code 88188 describes interpretation of flow cytometry results involving nine to 15 markers. The service is typically performed by a clinician such as a pathologist who reviews flow cytometry data to provide a diagnostic interpretation.
-
Service type: Clinical laboratory interpretation of multiparameter flow cytometry
-
Typical site of service: Clinical laboratory or pathology department, often within hospital outpatient departments or independent diagnostic laboratories
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A hematology-oncology patient presents with progressive lymphadenopathy, unexplained cytopenias, or an abnormal peripheral blood smear suggesting a possible lymphoproliferative disorder. The treating team orders flow cytometry to evaluate lymphoid and myeloid cell populations. A pathologist or clinical laboratory immunologist performs interpretation of multi-parameter flow cytometry panels covering nine to 15 markers (CPT 88188) to characterize cell lineage, maturation, clonality, and aberrant antigen expression.
The clinical workflow: after the clinician obtains a specimen (peripheral blood, bone marrow aspirate, or lymph node fine-needle aspirate), the specimen is sent to the flow cytometry laboratory. Technologists prepare and run multi-color antibody panels. The pathologist reviews cytometric histograms, dot plots, and quantitative marker expression and generates an interpretive report including gating strategy, percent populations, immunophenotype, and diagnostic impression (for example, consistent with chronic lymphocytic leukemia, acute leukemia with aberrant myeloid markers, or reactive lymphocytosis). The interpreted report guides downstream care such as targeted molecular testing, hematology referral, chemotherapy selection, or surveillance.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |